Kornitzer Capital Management Inc Castle Biosciences Inc Transaction History
Kornitzer Capital Management Inc
- $4.91 Billion
- Q4 2024
A detailed history of Kornitzer Capital Management Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 383,974 shares of CSTL stock, worth $7.66 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
383,974
Previous 407,238
5.71%
Holding current value
$7.66 Million
Previous $11.6 Million
11.9%
% of portfolio
0.21%
Previous 0.22%
Shares
13 transactions
Others Institutions Holding CSTL
# of Institutions
208Shares Held
25.8MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$60.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$36.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$35.8 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$28.6 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$19.9 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $524M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...